文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance.

作者信息

Rampioni Vinciguerra Gian Luca, Capece Marina, Distefano Rosario, Nigita Giovanni, Vecchione Andrea, Lovat Francesca, Croce Carlo M

机构信息

Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA.

Department of Clinical and Molecular Medicine, University of Rome 'Sapienza', Sant'Andrea Hospital, Rome, 00189, Italy.

出版信息

Signal Transduct Target Ther. 2023 Jan 27;8(1):37. doi: 10.1038/s41392-022-01228-z.

DOI:10.1038/s41392-022-01228-z

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9879967/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08aa/9879967/c202146232e7/41392_2022_1228_Fig1_HTML.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08aa/9879967/c202146232e7/41392_2022_1228_Fig1_HTML.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08aa/9879967/c202146232e7/41392_2022_1228_Fig1_HTML.jpg

相似文献

[1]

Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance.

Signal Transduct Target Ther. 2023-1-27

[2]

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.

PLoS One. 2017-8-3

[3]

[MiR-192 confers cisplatin resistance by targeting Bim in lung cancer].

Zhongguo Fei Ai Za Zhi. 2014-5

[4]

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.

EBioMedicine. 2018-8-23

[5]

MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.

Thorac Cancer. 2022-2

[6]

Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.

Mol Cell Biochem. 2021-6

[7]

LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.

Cancer Biol Ther. 2018-11-27

[8]

miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.

Oncotarget. 2016-4-26

[9]

MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.

Aging (Albany NY). 2019-4-12

[10]

Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement.

Bioengineered. 2022-2

引用本文的文献

[1]

Noncoding RNAs as regulators of FOSL1 in cancer.

Front Immunol. 2025-8-1

[2]

miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation.

J Exp Clin Cancer Res. 2025-3-14

[3]

Mechanistic Insights of hsa-mir-301a Regulation by Tobacco Smoke in Lung Squamous Cell Carcinoma: Evidence From Bioinformatics Analysis.

Bioinform Biol Insights. 2024-11-28

[4]

CAP superfamily proteins in human: a new target for cancer therapy.

Med Oncol. 2024-11-5

[5]

Multifaceted role of microRNA-301a in human cancer: from biomarker potential to therapeutic targeting.

Cancer Gene Ther. 2024-12

[6]

CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation.

Cell Death Discov. 2024-2-15

[7]

Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.

Signal Transduct Target Ther. 2024-2-12

[8]

Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.

Front Oncol. 2023-9-8

[9]

The potential of activator protein 1 (AP-1) in cancer targeted therapy.

Front Immunol. 2023

[10]

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases.

Drug Des Devel Ther. 2023

本文引用的文献

[1]

Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.

Cancer Gene Ther. 2022-3

[2]

AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma.

Nat Commun. 2020-10-8

[3]

lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.

Mol Ther Nucleic Acids. 2020-3-6

[4]

New developments on the Encyclopedia of DNA Elements (ENCODE) data portal.

Nucleic Acids Res. 2020-1-8

[5]

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.

JAMA. 2019-8-27

[6]

lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.

Mol Ther Nucleic Acids. 2019-9-6

[7]

Modulation of tumorigenesis by the pro-inflammatory microRNA miR-301a in mouse models of lung cancer and colorectal cancer.

Cell Discov. 2015-5-19

[8]

The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins.

Database (Oxford). 2016-7-3

[9]

Predicting effective microRNA target sites in mammalian mRNAs.

Elife. 2015-8-12

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索